申请人:MERRELL PHARMACEUTICALS INC.
公开号:EP0503563A2
公开(公告)日:1992-09-16
The present invention relates to certain novel 8-substituted purines as selective A₁-adenosine receptor antagonists which are useful in the treatment of patients suffering from Alzheimer's disease, congestive heart failure or pulmonary bronchoconstriction.
本发明涉及某些新型 8-取代嘌呤作为选择性 A₁-腺苷受体拮抗剂,可用于治疗阿尔茨海默病、充血性心力衰竭或肺支气管收缩患者。